Abiopharma

🔍 WANG YUFAN STEPHANIE (Executive)

Company: PROGRESS SOFTWARE CORP /MA (PRGS)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 1,070 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 6,826.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 486 shares of Common Stock at $24.96 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 6,340.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 1,038 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 7,378.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 471 shares of Common Stock at $24.96 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 6,907.00 | transaction_form_type: 4 | Footnotes: F3
• Acquired 1,201 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,108.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 545 shares of Common Stock at $24.96 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 7,563.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 1,070 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F5, F5
• Sold 1,038 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,076.00 | transaction_form_type: 4 | Footnotes: F1, F6, F6
• Sold 1,201 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,805.00 | transaction_form_type: 4 | Footnotes: F1, F7, F7

Footnotes:

• F1: Restricted stock units convert into common stock on a one-for-one basis.
• F2: Represents shares of common stock withheld by Progress Software Corporation (the "Company") to pay the tax withholding obligations of the Reporting Person upon the vesting of restricted stock units granted to the Reporting Person on January 19, 2023.
• F3: Represents shares of common stock withheld by the Company to pay the tax withholding obligations of the Reporting Person upon the vesting of restricted stock units granted to the Reporting Person on January 18, 2024.
• F4: Represents shares of common stock withheld by the Company to pay the tax withholding obligations of the Reporting Person upon the vesting of restricted stock units granted to the Reporting Person on January 23, 2025.
• F5: On January 19, 2023, the Reporting Person was granted 6,419 restricted stock units pursuant to the Company's 2008 Stock Option and Incentive Plan (as amended and restated, the "Plan"). The restricted stock units vest in six equal semiannual installments beginning October 1, 2023, subject to the continued employment of the Reporting Person with the Company.
• F6: On January 18, 2024, the Reporting Person was granted 6,226 restricted stock units pursuant to the Plan. The restricted stock units vest in six equal semiannual installments beginning October 1, 2024, subject to the continued employment of the Reporting Person with the Company.
• F7: On January 23, 2025, the Reporting Person was granted 7,207 restricted stock units pursuant to the Plan. The restricted stock units vest in six equal semiannual installments beginning October 1, 2025, subject to the continued employment of the Reporting Person with the Company.